Meghmani Q1: consolidated PAT nearly quadruples YoY to ₹48 Cr on margin rebound, revenue slips 12%
PAT +280% YoY · revenue -11.5% · margins expanding
₹542.83 Cr
-11.5% YoY
₹48.19 Cr
+280% YoY
8.69%
+6.7pp YoY
₹1.9
Meghmani Organics reported a profitability-led first quarter: consolidated PAT rose to ₹48.19 Cr from ₹12.68 Cr a year ago (+280% YoY) even as consolidated revenue fell 11.5% YoY to ₹542.83 Cr. There were no exceptional items on either side, so the profit surge is underlying, not accounting-driven — net margin expanded to ~8.9% from ~2.0%. The engine was cost and mix, not volume: consolidated finance costs more than halved to ₹13.05 Cr (from ₹29.47 Cr), the Pigments segment swung to a ₹2.85 Cr result from a ₹11.15 Cr loss, and the Others (Crop Nutrition/merchant) segment turned to a ₹7.02 Cr profit from a loss — while Agrochemicals, the topline mainstay, saw revenue drop ~14.5% YoY to ₹391.61 Cr with segment profit roughly flat at ₹70.06 Cr.
Q1 FY-2027 vs prior quarters
Basis matters this quarter. Standalone PAT of ₹57.60 Cr (+42% YoY) tells a much milder story than the +280% consolidated print; the gap is that subsidiary losses narrowed dramatically (group carried ~₹9.4 Cr of subsidiary drag this quarter versus ~₹28 Cr a year ago), so the consolidated number flatters the operational improvement. Readers will see both — the ~238-point divergence in YoY PAT growth is entirely the subsidiary turnaround, chiefly Kilburn Chemicals/pigments. Sequentially the base was depressed (Q4 FY26 PAT ₹8.03 Cr), so the +500% QoQ jump overstates momentum.
The stock went into the print at ₹59.94, up 23.1% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 2 consecutive quarters.
Management guides for a significant recovery in FY27, led by double-digit revenue growth in the core Crop Protection segment with an EBITDA margin rebound targeted at 15-17%. The nascent Crop Nutrition division, powered by new approvals for nano fertilizers (DAP, NPK, Zinc), is positioned as a key long-term growth driv
— This quarter: missed
Against management's own FY27 guidance the read is mixed: the targeted margin rebound and Pigments profitability recovery are clearly materialising, but the promised double-digit Crop Protection revenue growth did not show — core Agrochemicals revenue is down, not up. No formal street consensus was available for the quarter. The board separately appointed Naresh Prajapati as Company Secretary and Compliance Officer effective July 29, and the proposed amalgamation of wholly-owned subsidiaries Kilburn Chemicals and Meghmani Crop Nutrition (appointed date Jan 1, 2026) remains pending effectiveness with no accounting impact yet given. The July 22 volume-movement clarification sits against a quarter where the profit recovery ran ahead of the topline.
W1
Agrochemicals revenue trajectory vs guided double-digit FY27 growth — core revenue still -14.5% YoY at ₹391.61 Cr
W2
Whether margin rebound holds toward the guided 15-17% EBITDA band — net margin already at ~8.9% this quarter
W3
Sustained Pigments/Kilburn profitability (₹2.85 Cr this quarter) and progress of the subsidiary amalgamation; guided FY27 dividend resumption
Unit Lakh→Cr (÷100). No exceptional items either period. Consol PBT after ₹0.09L associate loss; NCI nil. Standalone PAT (₹57.6 Cr) exceeds consol (₹48.2 Cr) — subsidiaries (Kilburn/Crop Nutrition/Brazil) still net-loss but sharply narrowed vs year-ago; digital text, headers unambiguous.
Profitability beat masks revenue miss; macro headwinds vs growth guidance
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Guidance for 'double-digit Crop Protection growth' faced -12% Q1 miss. Pigments profitability beat vs prior expectation. TiO2 offline as disclosed. Mixed track record this quarter.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 revenue missed prior 'double-digit growth' guidance by 22pp (-12% delivered), driven by 17% volume decline in Latin America and macro price pressure. Profitability beat (18% EBITDA margin, 280% PAT growth YoY) masks underlying capacity utilization stress and demand softness. Long-term Crop Protection and Crop Nutrition growth theses remain intact; Pigments improving; but near-term macro headwinds unresolved.
₹542.8 Cr
Revenue · −11.5% YoY₹48.2 Cr
Reported PAT · +280% YoYExpanding
Margins · vs guidance: OverstatedDid the claims hold up?
Double-digit revenue growth in Crop Protection segment
MISSQ1 delivered -12% YoY decline (₹391 Cr); volume down 17%
EBITDA margin rebound targeted 15-17%
METConsolidated Q1 achieved 18%, Crop Protection 19.9%, Pigments 12.1%
Profitability improvement in Pigments segment
OVERSTATEDQ1 EBITDA margin 12.1% vs prior year ~3%; but mgmt flags as 'odd quarter', targets ~10%
Crop Nutrition nano fertilizers driving growth
METPositive contribution confirmed; ₹100 Cr guidance over 2-3 years (modest ramp)
TiO2 suspended due to commercial unviability
METConfirmed; negative EBITDA ₹3 Cr Q1, annualized ₹10-12 Cr loss; sulfur costs 8-10x higher
Earnings quality
What changed since the last call
Revenue guidance execution
DowngradePrior: 'double-digit growth'. Delivered: -12% YoY in Q1 Crop Protection. Mgmt maintains long-term view but admits 'one or two quarters might be little difficult'.
Pigments profitability trajectory
UpgradeMargin 12.1% this quarter vs ~3% prior year; but management flags as 'odd quarter', targets ~10% normalized. Better than prior expectation but not sustainable at current level.
Nano fertilizer commercialization
NewAdded Nano DAP, Nano NPK, Nano Zinc beyond Nano Urea. Trial orders received globally. ₹100 Cr revenue guidance over 2-3 years.
TiO2 restart timing
WithdrawnPrior: 'temporarily suspended'. Now: indefinite suspension pending sulfur normalization (currently 8-10x normal cost) and anti-dumping duty restoration. No timeline given.
The Q&A
Analysts pressed on Pigments sustainability (margin cyclical?), TiO2 restart (no timeline), and revenue miss vs guidance. Management held firm on long-term growth story but acknowledged near-term macro as headwind beyond control. Candid on volume-pricing split (17% volume, 5-6% pricing). Tone was pragmatic, not defensive.
Pigments demand outlook — Rohit Sinha, Sunidhi Securities
AnsweredUtilization may stay in this range. Revenue guidance ₹550-600 Cr annualized. Tariff headwind from prior year now over; improvements visible from cost reduction efforts.
Crop Protection growth — Rohit Sinha, Sunidhi Securities
PartialVery optimistic on growth over next 2-3 years due to new registrations and product development. Double-digit growth expected with healthy margin improvement.
Prior peak revenue guidance — Harshit Singhania, Robo Capital
AnsweredNo such guidance given. Crop Protection guidance: double-digit growth over 2-3 years at 15-17% margin. At 85-90% utilization: ₹2,500-3,000 Cr. Pigments: ₹500-600 Cr (no big capex).
Pigments margin sustainability — Abhishek Jain, Kriis PMS
PartialWill try to maintain ₹500-600 Cr revenue and ~10% margin via corrective actions on operational cost. Realization pressure real but will focus on profitability.
Pigment margin expansion breakdown — Abhishek Jain, Kriis PMS
AnsweredAbout 5-6% from better realization; balance from efficiency improvements undertaken over the past year.
Inventory position — Abhishek Jain, Kriis PMS
AnsweredNot much inventory at customer or distributor level; buying on spot basis by requirement. Healthy demand in both segments; macro is the only volatile factor.
Amalgamation impact — Abhishek Jain, Kriis PMS
PartialAmalgamation of wholly owned subsidiaries using pooling method. Consolidated financials continue. Benefits from cost reduction and operational discipline (multiple stock points closure).
Nano Urea sales trajectory — Nipun Sharma, VLS Finance
PartialCannot disclose volume, but relatively healthy growth in domestic and global. Long-term: couple of INR100 Cr revenue over 2-3 years from entire Nano fertilizer basket.
Pigments run-rate sustainability — Nipun Sharma, VLS Finance
AnsweredTop line roughly in this range Q-o-Q. Bottom line this quarter was higher; prefer to target ~10% EBITDA margin. Yes, revenue is quarterly run rate.
Pigment byproduct utilization — Love Gupta, Counter Cyclical Investments
PartialMOL also converts products to fertilizer; product-by-product differs. Have been doing this for many years and selling.
Pigment industry consolidation — Love Gupta, Counter Cyclical Investments
AnsweredCapacity utilization reduced across companies due to higher cost and lower demand. Industry is stagnant; little M&A activity expected.
TiO2 EBITDA loss quantification — Abhishek Jain, Kriis PMS
AnsweredKilburn Chemicals (TiO2): negative EBITDA ₹3 Cr Q1. Overall loss if suspended full year: ~₹10-12 Cr. Suspension has reduced the loss significantly.
Consolidated margin target FY27 — Abhishek Jain, Kriis PMS
Answered15-16% overall very high. Crop Protection targets 15-17% (industry avg), Pigments ~10%, consolidated expected 12-13% due to other segment effects and TiO2 drag.
Debt repayment interest savings — Abhishek Jain, Kriis PMS
AnsweredAnnual repayment ~₹130 Cr at 7% avg cost = ~₹9 Cr annual interest saving.
Finance cost reduction drivers — N.M. Modi, Individual Investor
AnsweredTwo reasons: (1) Switched to INR debt (lower rates, no MTM loss vs prior FX volatility). (2) Debt reduction repayment ongoing. Going forward, MTM impact minimal; continuous debt reduction with no heavy capex.
Volume vs pricing bifurcation — Mohit, Shubh Labh Research
Answered17% volume reduction. Company focused on profitability via product mix rather than top-line; pricing was selective based on market conditions.
Geographic decline attribution — Mohit, Shubh Labh Research
AnsweredPrimarily Latin America. Demand there slowly improving but pricing pressure from global macro and input cost increase.
Competitive pressure vs macro — Mohit, Shubh Labh Research
AnsweredDemand is there gradually improving. Pressure is from pricing due to global macro input cost rise. Company prefers to focus on bottom-line rather than chase top-line growth.
Nine-month outlook — Mohit, Shubh Labh Research
PartialVery optimistic on overall year and next 2-3 years. Maybe 1-2 quarters difficult near-term. Healthy growth expected in Crop Protection and Nutrition; Pigments stable top-line with better profitability.
Pigments forward guidance — Nachiket Kale, NK Research
AnsweredTop-line can be maintained around this level. Bottom-line may vary +/- but targeting ~10% EBITDA.
TiO2 restart expectations — Ansh Sharma, Individual Investor
AnsweredWaiting for two factors: (1) raw material (sulfur/acid) price normalization—currently 8-10x normal cost, driven by Middle East war; (2) anti-dumping duty restoration. No timeline; operation suspended indefinitely.
Guidance
Crop Protection: double-digit growth over next 2-3 years
MediumQ1 missed (-12% YoY). Management maintains guidance but acknowledges near-term macro headwinds. 85-90% utilization could support ₹2,500-3,000 Cr peak
Pigments: ₹550-600 Cr annualized
HighQ1 annualized ~₹524 Cr; steady-state targeting 40-50% utilization. No major capex. Supported by margin focus strategy
Crop Nutrition: ₹100 Cr revenue over 2-3 years
MediumFrom a small base; trial orders received globally. Dependent on regulatory approvals and market adoption of nano products
Crop Protection: 15-17% EBITDA (industry average)
MediumQ1 delivered 19.9%, above guidance. Sustainability dependent on volume recovery and pricing stability amid macro pressure
Pigments: ~10% EBITDA (medium-term target)
MediumQ1 was 12.1% ('odd quarter'). Management expects normalization to ~10%. Driven by operational efficiency, not top-line growth
Consolidated: 12-13% EBITDA
MediumImplies mix of Crop Protection ~16%, Pigments ~10%, Nano modest contribution, TiO2 drag ~₹10-12 Cr annual loss
No heavy capex planned for next 1-2 years
HighDebt repayment prioritized (₹130 Cr/year). Pigments no expansion capex; Crop Nutrition capex modest for product development
Risks the call surfaced
Demand/volume weakness
HighQ1 volume down 17% YoY, primarily Latin America. Despite management saying 'demand is there gradually', the 12% revenue decline contradicts prior 'double-digit growth' guidance. Q1 miss by 22pp.
Raw material cost inflation
HighSulfur/sulfuric acid: 8-10x price increase (₹4-5 to ₹35-40). Driven by Middle East geopolitical tensions. TiO2 plant offline indefinitely as a result. No normalization timeline visible.
TiO2 plant suspended indefinitely
HighTiO2 operations suspended due to commercial unviability. No timeline for restart. Waiting for: (a) sulfur price normalization, (b) anti-dumping duty restoration. Annualized loss ₹10-12 Cr if suspended full FY27.
Capacity utilization pressure
MediumCrop Protection 63% utilization, Pigments 39%. Soft demand and macro volatility prevent ramp-up. Management prioritizes profitability over growth, indicating limited confidence in near-term volume recovery.
Geographic concentration (Latin America)
MediumLatin America was primary driver of Q1 volume decline. Weather, demand, and pricing pressure in the region directly impacted consolidated revenue. Recovery dependent on macro stabilization there.
Management
Score 7/10. Transparent on challenges (volume decline, macro pressures). Candid on Q1 miss vs prior guidance. Provided specific numbers (17% volume, 5-6% pricing, ₹100 Cr Nano guidance). Did not shy away from TiO2 indefinite suspension. Q&A was direct, not evasive. Mixed. Crop Protection double-digit growth guidance MISSED (-12% YoY, -22pp miss). Pigments profitability BEAT (12.1% vs 3% prior), but flagged as 'odd quarter'. Debt repayment on track (₹32 Cr Q1, ₹130 Cr/year plan). EBITDA margin BEAT (18% vs 15-17% target).
1 · Q2-Q3 FY27
Latin America demand recovery and price stabilization on raw materials
2 · Over next 2-3 years
Crop Nutrition nano fertilizers scale to ₹100 Cr; Crop Protection double-digit growth ramp
3 · TBD
Sulfur/sulfuric acid price normalization; anti-dumping duty restoration for TiO2 restart
Long-term Crop Protection and Crop Nutrition growth theses remain intact; Pigments improving; but near-term macro headwinds unresolved.
Profitability beat masks volume collapse; revenue guidance missed by 22pp
EBITDA margin jumped 720bp to 18% and PAT swung to ₹48 Cr, but the quarter revealed structural demand weakness: Crop Protection volume down 17%, consolidated revenue fell 11.5%, and the 'double-digit growth' guidance now looks out of reach near-term. The street marked it down 3.48% by day 3 — and the margin beat does not offset the revenue miss.
Meghmani Organics posted EBITDA margin of 18% in Q1 FY27 — above its 15–17% target — and swung PAT to a 280% year-on-year gain. On the surface, a clean beat. But revenue of ₹542.8 Cr fell 11.5% YoY and the Crop Protection segment, 75% of sales, delivered ₹391 Cr (down 12%), the opposite of the 'double-digit growth' management had guided. The margin beat masks a quarter of structural demand stress: volume collapsed 17% in Crop Protection, capacity utilization sits at 63% (target 85–90%), and macro headwinds in raw materials and Latin America remain unresolved. The street understood: the stock fell 1.81% on day 1 and faded to a 3.48% loss by day 3 — a vote of no confidence in the reported print.
Where the profit came from
The 280% PAT surge is partly optical: the prior-year base was depressed (~₹17 Cr), and this quarter's ₹48.2 Cr benefited from a sharp margin rebound. But the underlying architecture matters. EBITDA expanded 46% to ₹97.9 Cr, a 720bp margin gain. This margin beat is real — achieved through operational efficiency and product mix discipline — but it arrived in a quarter of falling volume. That is the tension: management prioritized profitability over growth, a rational response to demand weakness, but it also signals limited confidence in a quick recovery.
₹542.8 Cr
-11.5% YoY
₹97.9 Cr
+46% YoY, 18% margin
₹48.2 Cr
+280% YoY
-17%
YoY
Management claims vs. what holds up
Crop Protection: double-digit revenue growth over next 2–3 years
ContradictedQ1: -12% YoY (₹391 Cr); volume -17%
EBITDA margin rebound to 15–17%
SupportedConsolidated 18%, Crop Protection 19.9%, Pigments 12.1%
Pigments segment profitability improvement
OverstatedMargin 12.1% vs 3% prior year; mgmt flags as 'odd quarter', targets ~10%
Nano fertilizers (DAP, NPK, Zinc) positioning for growth
SupportedTrial orders received globally; ₹100 Cr revenue guidance over 2–3 years
TiO2 suspended due to commercial unviability
SupportedConfirmed; negative EBITDA ₹3 Cr Q1, annualized ₹10–12 Cr loss
The volume miss is the story
17% volume decline in Crop Protection, the core business, is not a macro hiccup — it is a demand signal. Management attributed the miss to Latin America weakness and global macro pressure, and the pricing data backs it: realization was up 5–6%, offsetting roughly a third of the volume loss but leaving a net -12% revenue hit. Capacity utilization at 63% (Pigments even worse at 39%) means the company has headroom to absorb higher volumes but has none of the volume to absorb. For a company that guided double-digit growth in Crop Protection over a 2–3 year horizon, a Q1 miss this wide (22 percentage points) opens a critical question: has the market structurally softened, or is this a one- or two-quarter trough? Management says 'very optimistic' on the long-term but acknowledged 'one or two quarters might be little difficult' — a diplomatic way of saying near-term is opaque.
What changed on this call
Crop Protection revenue guidance execution: MISSED
Nano fertilizer product basket expanded (DAP, NPK, Zinc added to Urea)
Pigments profitability beat (12.1% vs prior ~3%), but flagged unsustainable
TiO2 restart indefinitely delayed; no timeline; annual drag ₹10–12 Cr
Debt reduction accelerating (₹32 Cr Q1, ₹130 Cr annual target at 7% cost)
The bull-bear ledger
EBITDA margin beat (18% vs 15–17% target) signals operational discipline
Pigments profitability recovered (though 'odd quarter'); targets ~10% sustained
Crop Nutrition nano fertilizer basket maturing (trial orders, regulatory approvals in progress)
Debt repayment momentum (₹130 Cr/year annualized; zero heavy capex planned next 1–2 years)
Revenue guidance for Crop Protection MISSED by 22pp (-12% vs double-digit target)
17% volume decline in core Crop Protection indicates structural, not cyclical, weakness
Capacity utilization stress: 63% Crop Prot, 39% Pigments (target 85–90%)
TiO2 plant offline indefinitely; annual loss ₹10–12 Cr if suspension continues; sulfur cost 8–10x normal
Latin America demand soft; recovery timing unclear
Risks, ranked by severity
Structural demand collapse in Crop Protection
High17% volume decline contradicts prior guidance for double-digit growth. If structural (not cyclical), the ₹2,500–3,000 Cr peak-capacity revenue targets are aspirational, not base-case.
Raw material cost inflation (sulfur 8–10x normal)
HighDriven by Middle East geopolitics; no normalization timeline visible. TiO2 plant remains offline indefinitely. Annual drag ₹10–12 Cr if suspension continues.
Capacity utilization pressure
Medium63% Crop Protection, 39% Pigments utilization. Company lacks pricing power in soft demand. Upside limited until volume recovery evident.
Latin America concentration
MediumMajority of Q1 revenue decline from one region. Geopolitical and macro volatility in LA are outside management control; recovery dependent on external factors.
Pigments margin mean-reversion
Medium12.1% this quarter is flagged as 'odd'; target ~10%. If realization pressure resumes or tariff headwinds return, expect margin to compress.
How the street is positioned
The stock fell 1.81% on day 1 post-result and continued lower to -3.48% by day 3. There was no post-earnings pop; the market interpreted the reported 280% PAT beat and margin expansion as insufficient compensation for the revenue miss and forward guidance shortfall. At ₹54.36, the stock trades above its 20-day average (₹51.3) and 50-day average (₹49.91) but below its 200-day average (₹56.75), positioning it in weak technical context. The stock is down 34.86% from its all-time high but up 48.93% from its 52-week low — a recovery that has now stalled.
Institutional support is minimal. FII ownership stands at 1.34% (down marginally from 1.48% a quarter prior), and DII shows no presence (0%). There is no institutional bid under the stock. Bulk deals over the past six months show routine trading by NK Securities Research and QE Securities in the ₹57–58 range — neutral positioning, no insider or promoter accumulation or selling near the highs. This is consistent with a stock the market views as fairly valued or slightly expensive at the current level, pending evidence of demand recovery.
₹54.36
as of Aug 3, 2026
₹36.5–₹83.45
-34.86% from ATH
₹51.3
Above
-1.81%
Post-result fade
What to watch next
1 · Q2 Crop Protection volume trend
The 17% YoY decline in Q1 is the core question. If Q2 shows stabilization or modest recovery (say, -5% to flat YoY), the trough narrative holds. If volume remains down 15%+, the risk shifts to structural demand erosion vs. cyclical macro pressure.
2 · Raw material cost trajectory (sulfur specifically)
Sulfur is currently ₹35–40 vs ₹4–5 normal, an 8–10x spike. Any move toward normalization is a catalyst for TiO2 restart and margin relief. Watch global commodity prices and Middle East supply signals.
3 · Nano fertilizer commercialization (trial → revenue)
Management flagged trial orders globally for Nano DAP, NPK, and Zinc. Proof of concept is the next milestone. The ₹100 Cr revenue guidance over 2–3 years is not near-term, but early adoption metrics would validate the thesis.
The single number to track
Crop Protection volume YoY trend. If Q1's -17% YoY was a trough and Q2–Q3 show recovery toward flat or single-digit growth, the long-term thesis re-rates higher. If volume decline persists in double digits, the market will reprice the 'double-digit growth' guidance lower. This is the earnings barometer.
Meghmani Organics is not broken — margin quality is real, debt reduction is on track, and the long-term Crop Protection and Crop Nutrition opportunity is credible. But Q1 revealed that the near-term is tougher than management's guidance suggested. A 22-percentage-point miss on the Crop Protection growth target, 17% volume decline, and 40 percentage points of capacity spare at core facilities are not margin-beat optics. The street was right to mark it down 3.48% by day 3. A hold is the right call: steady execution, not a step-change. Wait for Q2 volume data and evidence that the trough is behind before adding exposure. The margin recovery is encouraging, but it masks, not solves, the near-term demand challenge.